Dr. Neil D. Belman

Oncology
206 7th St, 
Coaldale, PA 
Offers Telehealth
206 7th St, 
Coaldale, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Neil Belman is an Oncologist in Coaldale, Pennsylvania. Dr. Belman is rated as an Experienced provider by MediFind in the treatment of Prothrombin Deficiency. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Lung Adenocarcinoma, Non-Small Cell Lung Cancer (NSCLC), and Bone Marrow Aspiration.

His clinical research consists of co-authoring 4 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Oncology
Licenses
Internal Medicine in PA
Hospital Affiliations
St Luke's Miners Memorial Hospital
St Luke's Hospital Bethlehem
St Luke's Hospital - Monroe Campus
Geisinger St. Luke's Hospital
St Luke's Hospital - Anderson Campus
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

ST LUKES PHYSICIAN GROUP INC
206 7th St, Coaldale, PA 18218
Other Locations
ST LUKES PHYSICIAN GROUP INC
1872 St Lukes Blvd, Fl 1, Easton, PA 18045
ST LUKES PHYSICIAN GROUP INC
1736 Hamilton St, Allentown, PA 18104
ST LUKES PHYSICIAN GROUP INC
701 Ostrum St, Fountain Hill, PA 18015

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Enrollment Status: Active_not_recruiting
Publish Date: December 17, 2025
Intervention Type: Other, Procedure, Biological, Drug
Study Phase: Not Applicable
An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Enrollment Status: Active_not_recruiting
Publish Date: December 10, 2025
Intervention Type: Drug
Study Drugs: Itacitinib, Osimertinib
Study Phase: Phase 1/Phase 2
Randomized Study of Erlotinib Vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)
Randomized Study of Erlotinib Vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)
Enrollment Status: Active_not_recruiting
Publish Date: December 04, 2025
Intervention Type: Other, Drug
Study Drug: Erlotinib Hydrochloride
Study Phase: Phase 3
Randomized Phase II Open Label Study of Lenalidomide R-CHOP (R2CHOP) vs. RCHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone) in Patients With Newly Diagnosed Diffuse Large B Cell Lymphoma
Randomized Phase II Open Label Study of Lenalidomide R-CHOP (R2CHOP) vs. RCHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone) in Patients With Newly Diagnosed Diffuse Large B Cell Lymphoma
Enrollment Status: Active_not_recruiting
Publish Date: November 28, 2025
Intervention Type: Drug, Biological, Other
Study Drugs: Cyclophosphamide, Doxorubicin Hydrochloride, Lenalidomide, Prednisone, Rituximab, Vincristine Sulfate
Study Phase: Phase 2
Adjuvant Nivolumab in Resected Lung Cancers (ANVIL)-A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers
Adjuvant Nivolumab in Resected Lung Cancers (ANVIL)-A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Intervention Type: Procedure, Biological, Other
Study Drug: Nivolumab
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Pilot Study of an Oral, Selective Peripheral Opioid Receptor Antagonist in Advanced Non-Small Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Pilot Study of an Oral, Selective Peripheral Opioid Receptor Antagonist in Advanced Non-Small Cell Lung Cancer
Enrollment Status: Terminated
Publish Date: July 17, 2025
Intervention Type: Other, Drug
Study Drug: Naloxegol
Study Phase: Phase 2
Randomized Phase II Clinical Trial of Cisplatin/Carboplatin and Etoposide (CE) Alone or in Combination With Nivolumab as Frontline Therapy for Extensive Stage Small Cell Lung Cancer (ED-SCLC)
Randomized Phase II Clinical Trial of Cisplatin/Carboplatin and Etoposide (CE) Alone or in Combination With Nivolumab as Frontline Therapy for Extensive Stage Small Cell Lung Cancer (ED-SCLC)
Enrollment Status: Completed
Publish Date: July 03, 2025
Intervention Type: Drug, Biological
Study Drugs: Carboplatin, Cisplatin, Etoposide, Nivolumab
Study Phase: Phase 2
View 6 Less Clinical Trials

4 Total Publications

Intra-arterial Bevacizumab for Posterior Fossa Hemangioblastoma.
Intra-arterial Bevacizumab for Posterior Fossa Hemangioblastoma.
Journal: Cureus
Published: December 17, 2022
Similar Doctors
Advanced in Prothrombin Deficiency
Dr. Hyatt P. Iii
Hematology | Oncology
Advanced in Prothrombin Deficiency
Dr. Hyatt P. Iii
Hematology | Oncology

Lancaster Cancer Center, Ltd.

703 Lampeter Road, 
Lancaster, PA 
 (58.4 miles away)
717-291-1313
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Hyatt Iii is a Hematologist and an Oncologist in Lancaster, Pennsylvania. Dr. Iii is rated as a Distinguished provider by MediFind in the treatment of Prothrombin Deficiency. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Severe Congenital Neutropenia, and Congenital Afibrinogenemia. Dr. Iii is currently accepting new patients.

Experienced in Prothrombin Deficiency
Dr. Peter H. Cygan
Hematology Oncology | Hematology | Oncology
Experienced in Prothrombin Deficiency
Dr. Peter H. Cygan
Hematology Oncology | Hematology | Oncology

The Milton S Hershey Medical Center Physicians Group

500 University Dr, 
Hershey, PA 
 (55.6 miles away)
Languages Spoken:
English
See accepted insurances

Peter Cygan is a Hematologist Oncology specialist and a Hematologist in Hershey, Pennsylvania. Dr. Cygan is rated as an Advanced provider by MediFind in the treatment of Prothrombin Deficiency. His top areas of expertise are Hemophilia A, Von Willebrand Disease (VWD), Heyde Syndrome, Hemophilic Arthropathy, and Bone Marrow Aspiration.

Experienced in Prothrombin Deficiency
Dr. Daniel A. Forman
Hematology Oncology | Oncology
Experienced in Prothrombin Deficiency
Dr. Daniel A. Forman
Hematology Oncology | Oncology

The Milton S Hershey Medical Center Physicians Group

500 University Dr, 
Hershey, PA 
 (55.6 miles away)
717-531-8407
Languages Spoken:
English
See accepted insurances

Daniel Forman is a Hematologist Oncology specialist and an Oncologist in Hershey, Pennsylvania. Dr. Forman is rated as an Advanced provider by MediFind in the treatment of Prothrombin Deficiency. His top areas of expertise are Small Lymphocytic Lymphoma (SLL), Pulmonary Embolism, Multiple Myeloma, Disseminated Intravascular Coagulation, and Bone Marrow Aspiration.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Belman's expertise for a condition
ConditionClose
    View All 17 Distinguished Conditions
    View All 43 Advanced Conditions
    View All 89 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile